PDB reference: type II dehydroquinase, 4l8l
Introduction
Pseudomonas aeruginosa is one of the major causes of opportunistic infections (Chastre et al., 1988 (Chastre et al., , 1998 Chastre & Fagon, 2002; . P. aeruginosa is resistant to many antibiotics and disinfectants and is capable of growing in a variety of habitats, including soil, marshes and coastal marine habitats as well as on plants and animal tissue, including the lungs of cystic fibrosis patients (Chastre & Fagon, 2002; Chastre et al., 1988 Chastre et al., , 1989 Chastre et al., , 1998 Chastre, 2001; Chastre, Fagon, Bornet-Lecso et al., 1995; Chastre, Fagon & Trouillet, 1995; . Long-term P. aeruginosa infection is the primary cause of mortality of cystic fibrosis patients. P. aeruginosa is also a primary source of nosocomial infection, causing bacteremia in burns victims and urinary-tract infections in catheterized patients as well as pneumonia in patients on ventilators and respirators (Chastre & Fagon, 2002; Fagon, Chastre, Hance, Montravers et al., 1993; Fagon, Chastre, Hance, Domart et al., 1993; Fagon, Chastre, Domart et al., 1996; Fagon, Chastre, Vuagnat et al., 1996; . Thus, there is a need to develop new therapeutics to reduce the morbidity and mortality of P. aeruginosa infections because of its natural resistance to many conventional antibiotics.
Viable therapeutic targets include enzymes that are vital to bacteria but absent in mammals, such as enzymes from the shikimate pathway (Coggins et al., 2003) . The shikimate pathway produces chorismate from erythrose 4-phosphate and phosphoenolpyruvate and leads to the biochemical synthesis of aromatic amino acids, folic acid, ubiquinone and other aromatic compounds (Mousdale & Coggins, 1991; Abell, 1999; Haslam, 1993) . Dehydroquinases (DHQase) catalyze the interconversion of 3-dehydroquinate and 3dehydroshikimate ( Fig. 1a) , which is the third step in the shikimate pathway (Mousdale & Coggins, 1991; Abell, 1999) . There are two classes of DHQase and both classes have different structural, sequence, physical and biochemical properties. Structures of representative members from both classes have been solved. Although they catalyze the same reaction, type I and type II enzymes are structurally distinct (Gourley et al., 1999) . Type I DHQases typified by 3-dehydroquinate dehydratase from Salmonella typhimurium (Gourley et al., 1999) and S. enterica (Light et al., 2013) have the typical -barrel topology, whereas type II DHQases typified by homologs from Mycobacterium tuberculosis (Gourley et al., 1999) and Streptomyces coelicolor have a prototypical flavodoxin-like / topology. The active sites of type I and type II enzymes are different and the difference is evident when the structures of representative enzymes in complex with 3-dehydroshikimate are compared (Figs. 1b and 1c) . The active site of the representative type I structure from S. enterica (PDB entry 4gug; Light et al., 2013) cannot be superposed with that of the representative type II structure from M. tuberculosis (PDB entry 3n59; Dias et al., 2011) . This paper focuses on type II DHQase from P. aeruginosa because no type I DHQase was identified in the Pseudomonas genome using the Pseudomonas database (http://www.pseudomonas.com; Winsor et al., 2011) . Additionally, inhibitors of type II DHQase have been investigated as potential therapeutic targets for tuberculosis and have been shown to inhibit the growth of M. tuberculosis (Frederickson et al., 1999) . Type II DHQases form stable trimers and dodecamers and the functionally active oligomer is believed to be the dodecamer (Dias et al., 2011; Robinson et al., 2006) . The crystal structure of recombinant catalytically active type II DHQase from P. aeruginosa (PaDHQase) is reported here.
Materials and methods

Recombinant expression and production of PaDHQase
The amino-acid sequence of P. aeruginosa strain PAO1 (NCBI Reference Sequence NP_253533.1) was used as a template for the chemical synthesis of DNA expression constructs encoding the 147amino-acid protein with an N-terminal hexahistidine tag followed by a TEV protease cleavage site (GenScript USA Inc., Piscataway, New Jersey, USA). The synthetic construct was codon-optimized for expression in Escherichia coli and cloned into the HindIII/NdeI sites of pET-28a vector (Novagen, Madison, Wisconsin, USA). The plasmid was transformed into E. coli BL21-CodonPlus-(DE3)-RIPL (Stratagene) by heat shock. Positive colonies were identified by colony PCR with T7 promoter and T7 terminator primers (EMD Millipore, Rockland, Massachusetts, USA). A single positive colony was selected, verified and used for large-scale expression. Each 1 l culture was grown from a 25 ml overnight starter culture using 50 mg l À1 kanamycin. Protein induction was initiated by the addition of IPTG to a final concentration of 0.5 mM for 16 h at 28 C using NZYM medium.
The cell pellet was harvested by centrifugation and stored at À80 C until used; a pellet from a 1 l culture was resuspended in lysis buffer [100 ml phosphate-buffered saline (PBS) pH 7.4, 10%(v/v) glycerol, 5%(v/v) Triton X-100, 0.05%(v/v) -mercaptoethanol and one Roche cOmplete EDTA-free protease-inhibitor tablet] and lysed under high pressure in an Emulsiflex homogenizer (Avestin, Canada). The supernatant was separated from the cell debris by centrifugation at 8000g for 10 min. PaDHQase from the clarified supernatant was purified by Ni-affinity chromatography on a 5 ml HisTrap FF crude column (GE Healthcare, Piscataway, New Jersey, USA) using an Ä KTApurifier (GE Healthcare, Piscataway, New Jersey, USA). The binding buffer was PBS pH 7.4 with 20 mM imidazole. Protein elution was preceded with extensive washing with binding buffer to remove nonspecifically bound proteins. Upon elution with 250 mM imidazole, $99% pure protein was obtained as assessed by Coomassie-stained SDS-PAGE ( Fig. 2a ) and the final yield was $40 mg from 1 l culture.
Enzyme kinetics
Enzymatic activity was determined by monitoring the characteristic absorbance change at 234 nm resulting from the production of the product 3-dehydroshikimate. All kinetics runs were carried out at room temperature with reagents kept on ice until added to the well for a run. Reactions were incubated for approximately 10 s before starting a run. The substrate, 3-dehydroquinic acid (catalog No. 40216, molecular mass 228.24 g mol À1 ), was purchased from Sigma-Aldrich, St Louis, Missouri, USA. A 0.2 M stock solution of the substrate was prepared by dissolving 5 mg in 985 ml water just prior to performing each assay. Recombinant His-tagged PaDHQase was stored at À80 C in 50 ml aliquots for one-time thaw and use. Kinetic studies were performed using a Quant spectrophotometer and KC Junior software (BioTek, Winooski, Vermont, USA). The receptacle for each reaction was one well of a 96-well plate, with an extrapolated path length of 1 cm (for purposes of software absorbance calculation). All reaction conditions were prepared in a final volume of 100 ml. Varying concentrations of enzyme and substrate were added to determine the linear range of enzymatic activity and it was determined that 40 nM enzyme was within this range. Catalytic constants were determined from triplicate assays using 40 nM recombinant His-tagged PaDHQase in 50 mM Tris-HCl pH 7.0 at 25 C and concentrations of 3-dehydroquinic acid ranging from 2 to 15 mM. The absorbance measurements for each reaction were taken every 4 s for 6 min. The velocity values were calculated from the slopes of the absorbance versus time curves. The coefficient of molar absorption for the enone-carboxylate chromophore is 1.2 Â 10 4 (Gonzá lez-Bello & Castedo, 2007).
Crystallization and data collection
Crystals were grown at 20 C by vapor diffusion in sitting drops. Drops were prepared by mixing 2 ml protein solution at 4 mg ml À1 in 50 mM Tris-HCl pH 7.0 with 1 ml reservoir solution. The reservoir solution for the largest crystal consisted of a mixture of 0.8 M potassium sodium tartrate tetrahydrate, 0.1 M 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid (HEPES) pH 7.5. Large tetrahedral crystals were obtained after two weeks ( Fig. 2b) . (hkl)i are the intensity of the ith measurement of I(hkl) and the mean intensity of the reflection with indices hkl, respectively. ‡ R cryst = P hkl jF obs j À jF calc j = P hkl jF obs j, where F obs are observed and F calc are calculated structure-factor amplitudes. § The R free set consisted of a randomly chosen 5% of reflections. } PROCHECK validation was used (Laskowski et al., 1993) . RSZR is the root-mean-square of all Z scores. generator with VariMax HF optics. A data set was collected from a single crystal with a crystal-to-detector distance of 115 mm and exposure times of 59 s for 0.5 oscillations, using the CrystalClear (d*TREK) package (Pflugrath, 1999) . A sample diffraction image is shown in Fig. 2(c) . Data were processed using iMosflm (Battye et al., 2011) . The crystal belonged to the cubic space group F23 with unitcell parameters a = b = c = 125.39 Å .
Structure determination
The structure was solved by molecular replacement with Phaser (McCoy et al., 2005; Storoni et al., 2004 ). The search model was obtained by stripping a monomer of DHQase from M. tuberculosis of its water molecules (Gourley et al., 1999) . Molecular replacement was followed by iterative cycles of manual model building with Coot (Emsley et al., 2010) and structure refinement with REFMAC5 (Murshudov et al., 2011) within the CCP4 package . Unless otherwise noted, figures were generated using PyMOL (DeLano, 2002) . The refined model statistics are shown in Table 1 . The atomic coordinates have been deposited with the RCSB PDB with accession code 4l8l.
Results and discussion
PaDHQase is catalytically active
Preliminary kinetic parameters for the PaDHQase catalytic conversion of dehydroquinic acid to dehydroshikimic acid at 40 nM enzyme, pH 7 and 25 C are shown as the Michaelis-Menten curve (Fig. 3a) . The derived V max from this curve is 848.76 nM s À1 , with a K m of 2.94 mM and a k cat of 18.72 s À1 . These results indicate that the recombinant enzyme is catalytically active and suggest that PaDHQase belongs to the slow class of type II DHQases such as the homolog from M. tuberculosis (5.2 s À1 ), which has significantly lower k cat values than fast type II DHQases such as S. coelicolor (124 s À1 ) with high k cat values from 100 to 1000 s À1 (Evans et al., 2002) . 
Overall structure
The structure of PaDHQase was solved in the cubic space group F23. The refined model of PaDHQase has one monomer in the asymmetric unit with the classic type II DHQase superfamily topology (Fig. 3b) . The classic dodecamer observed in other bacterial DHQases is generated from the lattice symmetry elements (Fig. 3c) . The dodecamer and trimer are stable enough to be observed on the reduced SDS-PAGE gels of purified protein after boiling for 10 min in the presence of reducing agent and SDS (Fig. 2a) . The trimer interface is mediated by strong electrostatic interactions: only one of these contacts involves binding-cavity residues, the intermonomer salt bridge between Asp88 and Arg112 (Fig. 3d ). This salt bridge is conserved in the structures from other species (Gourley et al., 1999; Roszak et al., 2002; Gonzá lez-Bello & Castedo, 2007; Blanco et al., 2013; Coderch et al., 2014) . 138 of the 147 amino-acid residues are clearly visible in the 2F o À F c electron-density maps calculated from a molecular-replacement solution, and the quality of fit is evident from the final 2F o À F c electron-density maps (Fig. 3d ). The disordered regions in the structure are the N-terminal residues (hexahistidine tag as well as TEV cleavage site) and lid loop region. The quality of the final model is summarized in Table 1 .
Active site of PaDHQase
The active site of PaDHQase is typical of type II DHQases. It is in a cleft surrounded by the C-terminal edge of -sheets 1 and 3, which interacts with the 3 helix of a neighboring subunit at the trimer interface and is also held together by a salt bridge between Arg112 and Asp88 of these opposing subunits (Fig. 3d) . The active site typically includes a flexible lid, which closes over the active site upon substrate binding. The lid loop is disordered in our PaDHQase structure (Fig. 3b) , which is not unusual since the lid loop is disordered in other structures that lack a substrate or an inhibitor (Gourley et al., 1999) . The active site includes a substrate-binding cavity and a proximal glycerol-binding cavity (Dias et al., 2011) . Comparison of PaDHQase with other type II DHQases. The amino-acid sequence alignment showing structural elements of DHQase was generated with ESPript3.0 (Gouet et al., 2003) . Secondary-structure elements are as follows: -helices are shown as large squiggles labeled , 3 10 -helices are shown as small squiggles labeled , -strands are shown as arrows and are labeled . Identical residues are shown on a red background, conserved residues are shown in red and conserved regions are shown in blue boxes. The DHQases used in alignment were PaDHQase, recombinant PaDHQase (rPaDHQase), and others identified using the Structure Similarity option of PDBeFold (http:// www.ebi.ac.uk/msd-srv/ssm/) as most structurally similar to PaDHQase. ApHHQase is the crystal structure of DHQase from Actinobacillus pleuropneumoniae (PDB entry 1uqr), the most similar to PaDHQase, and has 66% sequence identity and an r.m.s.d. 0.63 Å (Maes et al., 2004) . YpDHQase, the crystal structure of the homolog from Yersinia pestis (PDB entry 3lwz), is the next closest structural homolog with 68% sequence identity and an r.m.s.d. of 0.75 Å (Center for Structural Genomics of Infectious Diseases, unpublished work). CaDHQase is the homolog from Candida albicans (PDB entry 3kip), which has 56% sequence identity and an r.m.s.d. of 0.76 Å (Trapani et al., 2010) . Other structurally similar type II DHQases include MtDHQase from M. tuberculosis (Gourley et al., 1999; Schmidt et al., 2013) Despite the use of glycerol as a cryoprotectant, there is no evidence of glycerol binding in the electron-density maps.
Comparison to other type II DHQases
The structures that were most similar to PaDHQase were identified using the Structure Similarity option of PDBeFold (http:// www.ebi.ac.uk/msd-srv/ssm/). This method identifies similar structures using the following criteria: the r.m.s.d. for alignment of all main-chain atoms, alignment length and number of gaps. ClustalW (Larkin et al., 2007) alignment of the top hits reveals well conserved amino-acid sequences (Fig. 4) . The structure of PaDHQase superposes quite well with these enzymes, with an r.m.s. deviation of all main-chain atoms ranging from 0.63 Å for the Actinobacillus pleuropneumoniae homolog to 1.2 Å for some of the M. tuberculosis homolog structures. The regions of highest structural variability for these structures tend to be in loop regions, most notably the flexiblelid regions, and are related to disorder in the absence of ligand binding and variable conformations dependent upon ligand type.
The enzymatic site of PaDHQase is accessible to small molecules and is quite similar to those of homologous enzymes, for example that from M. tuberculosis, and key residues involved in inhibitor and substrate binding are well conserved (Fig. 5 ). As was observed in other DHQases the active site of PaDHQase involves residues from two monomers (colored gray and aquamarine) and there are no amino-acid residues from either monomer obstructing access to the active site. The third monomer at the trimer interface (colored blue) is not in proximity to the active site ( Fig. 5 ). There are no inter-or intra-dodecamer contacts obstructing the active site.
The similarity of the crystal form and accessibility of the active site suggest the possibility of soaking inhibitors or other small molecules into the preformed crystals. Additionally, the binding cavity of PaDHQase extends into the glycerol-binding cavity, revealing that inhibitors such as compound 5 from the Blundell group which extends from the active site to the glycerol site (Dias et al., 2011) are capable of fitting into the PaDHQase structure and providing good starting points for structure-based inhibitor design. Overall the extensive structural similarity of PaDHQase to other type II DHQases suggests the possibility of shared inhibitors.
Concluding remarks
Structural studies of catalytically active recombinant PaDHQase reveal a prototypical type II DHQase with extensive structural similarity to previously characterized enzymes. Kinetic activity suggests that PaDHQase belongs to the slow class of type II DHQases. Rational drug-development efforts will benefit from the wealth of existing knowledge of enzymes from other organisms, particularly other slow-class members.
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